Two Sigma Investments’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95M | Sell |
940,582
-112,399
| -11% | -$233K | ﹤0.01% | 1814 |
|
2025
Q1 | $2.32M | Buy |
1,052,981
+62,812
| +6% | +$138K | 0.01% | 1600 |
|
2024
Q4 | $1.51M | Sell |
990,169
-411,906
| -29% | -$630K | ﹤0.01% | 1849 |
|
2024
Q3 | $2.79M | Buy |
1,402,075
+295,639
| +27% | +$588K | 0.01% | 1410 |
|
2024
Q2 | $3.87M | Buy |
1,106,436
+1,025,872
| +1,273% | +$3.59M | 0.01% | 1071 |
|
2024
Q1 | $223K | Buy |
+80,564
| New | +$223K | ﹤0.01% | 2600 |
|
2023
Q3 | – | Sell |
-36,500
| Closed | -$42.3K | – | 2984 |
|
2023
Q2 | $42.3K | Sell |
36,500
-112,000
| -75% | -$130K | ﹤0.01% | 2764 |
|
2023
Q1 | $224K | Sell |
148,500
-124,581
| -46% | -$188K | ﹤0.01% | 2444 |
|
2022
Q4 | $683K | Buy |
273,081
+120,863
| +79% | +$302K | ﹤0.01% | 1829 |
|
2022
Q3 | $642K | Buy |
152,218
+45,163
| +42% | +$190K | ﹤0.01% | 1613 |
|
2022
Q2 | $299K | Buy |
+107,055
| New | +$299K | ﹤0.01% | 1963 |
|
2020
Q2 | – | Sell |
-116,226
| Closed | -$1.36M | – | 2154 |
|
2020
Q1 | $1.36M | Sell |
116,226
-17,757
| -13% | -$208K | 0.01% | 830 |
|
2019
Q4 | $3.15M | Buy |
+133,983
| New | +$3.15M | 0.01% | 915 |
|
2018
Q3 | – | Sell |
-8,780
| Closed | -$341K | – | 2156 |
|
2018
Q2 | $341K | Buy |
+8,780
| New | +$341K | ﹤0.01% | 1750 |
|